Published in

Springer, Cancer Chemotherapy and Pharmacology, 2(84), p. 287-298, 2019

DOI: 10.1007/s00280-019-03844-z

Links

Tools

Export citation

Search in Google Scholar

SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4

Journal article published in 2019 by Deysi Viviana Tenazoa Wong, Helder Veras Ribeiro-Filho, Carlos Wagner Souza Wanderley, Caio Abner Vitorino Gonçalves Leite, Jonilson Berlink Lima, Alexia Nathália Brígido Assef, Aurilene Gomes Cajado, Gabriela Loiola Ponte Batista, Rafael Holanda González, Karla Oliveira Silva, Luis Philipi Carvalho Borges, Nylane Maria Nunes Alencar, Diego Veras Wilke, Thiago Mattar Cunha, Ana Carolina Migliorini Figueira and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO